AU5801196A - Relaxin diagnostic assays and kits, and methods and uses thereof - Google Patents

Relaxin diagnostic assays and kits, and methods and uses thereof

Info

Publication number
AU5801196A
AU5801196A AU58011/96A AU5801196A AU5801196A AU 5801196 A AU5801196 A AU 5801196A AU 58011/96 A AU58011/96 A AU 58011/96A AU 5801196 A AU5801196 A AU 5801196A AU 5801196 A AU5801196 A AU 5801196A
Authority
AU
Australia
Prior art keywords
relaxin
kits
methods
diagnostic assays
assays
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU58011/96A
Inventor
Edward P. Amento
Mark Erikson
Christian Schwabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medical University of South Carolina MUSC
Connective Therapeutics Inc
Original Assignee
University of South Carolina
Medical University of South Carolina MUSC
Connective Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of South Carolina, Medical University of South Carolina MUSC, Connective Therapeutics Inc filed Critical University of South Carolina
Publication of AU5801196A publication Critical patent/AU5801196A/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57488Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds identifable in body fluids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575Hormones
    • G01N2333/64Relaxins

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
AU58011/96A 1995-06-07 1996-05-16 Relaxin diagnostic assays and kits, and methods and uses thereof Abandoned AU5801196A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US48839995A 1995-06-07 1995-06-07
US488399 1995-06-07
PCT/US1996/007400 WO1996041167A1 (en) 1995-06-07 1996-05-16 Relaxin diagnostic assays and kits, and methods and uses thereof

Publications (1)

Publication Number Publication Date
AU5801196A true AU5801196A (en) 1996-12-30

Family

ID=23939578

Family Applications (1)

Application Number Title Priority Date Filing Date
AU58011/96A Abandoned AU5801196A (en) 1995-06-07 1996-05-16 Relaxin diagnostic assays and kits, and methods and uses thereof

Country Status (2)

Country Link
AU (1) AU5801196A (en)
WO (1) WO1996041167A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050032683A1 (en) 2000-10-04 2005-02-10 Amento Edward P. Methods of modulating apoptosis by administration of relaxin agonists or antagonists
US20040006205A1 (en) * 2001-04-03 2004-01-08 Li Li Therapeutic polypeptides, nucleic acids encoding same, and methods of use

Also Published As

Publication number Publication date
WO1996041167A1 (en) 1996-12-19

Similar Documents

Publication Publication Date Title
AU7142796A (en) Diagnosis method and reagents
AU2922497A (en) Detection probes, kits and assays
AU9104798A (en) Methods for selecting, developing and improving diagnostic tests for pregnancy-related conditions
AU4546396A (en) Assay device and method
AU5553496A (en) Differential separation assay methods and test kits
AU5871396A (en) Enzyme linked oligonucleotide assays (elonas)
AU7686094A (en) Method, reagent and kit for the detection of fecal occult blood
AU6243596A (en) Anti-Fas ligand antibody and assay method using the anti-Fas ligand antibody
AU6909096A (en) System and methods for performing rotor assays
AU2735797A (en) Detection probes, kits and assays
AU3702397A (en) Anti-herpesviral agents and assays therefor
GB9626932D0 (en) Assay methods and kits therefor
AU7247896A (en) Protein signature analysis
AU4963797A (en) Rapid microbiological assay
AU7575096A (en) Specimen identifier
AU6312896A (en) Sample analyzer
AU7541296A (en) Beta-fructofuranosidase, its preparation and uses
AU7294396A (en) Protein detection
AU6821796A (en) Contraceptive combined preparation, kits containing the same and contraceptive method using this combined preparation
AU1144097A (en) Ox-2 costimulatory molecule
AU4606196A (en) Assay, receptor proteins and ligands
AU3005595A (en) Method, reagents and kit for diagnosis and targeted screening for retinoblastoma
AU2452097A (en) Assays and reagents for identifying anti-fungal agents, and uses related thereto
AU2667197A (en) Stabilized preparations of human troponins and modifications thereof, diagnostic assay methods and assay kits
AU1110297A (en) Novel dnas, novel polypeptides and novel antibodies